Delivery Order SPE2DR25D9133-SPE2DR26FCFM2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,534.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit (6ml). The award, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in the open market. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $16,900.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of a Photrexa Cross-Linking Kit (6ml). This firm fixed-price delivery order was awarded on November 14, 2025, with an ultimate completion date of December 8, 2025, and will be performed at the vendor's Park Ridge location. The award was issued without a set-aside designation,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,450.43 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The delivery order, issued December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award...
- The Defense Logistics Agency issued a $11,267.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The award, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group...
- The Defense Logistics Agency issued a delivery order valued at $16,900.92 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit 6ML, a specialized pharmaceutical product. The contract was awarded on November 25, 2025, with an ultimate completion date of December 17, 2025, under firm fixed-price terms. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,816.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of a Photrexa Cross-Linking Kit (6ML). The contract is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, and was issued without a set-aside designation. DMS Pharmaceutical Group will perform the work at its facility in Park Ridge,...
- The Defense Logistics Agency awarded a delivery order valued at $11,267.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The contract, designated as delivery order 4570008681, carries a firm fixed-price structure with no set-aside designation and an ultimate completion date of December 2, 2025. This delivery order was issued under DMS Pharmaceutical Group's recently...
- The Defense Logistics Agency awarded a $3,727.51 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The award, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a delivery order valued at $14,910.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit in 6ml units. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a discrete task order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The company...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,450.43 to DMS Pharmaceutical Group Inc. on December 9, 2025, for the supply of Photrexa Cross-Linking Kit 6ML, a pharmaceutical product used in corneal cross-linking procedures. The award, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by December 31, 2025, and will be performed at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc.,...
- SPE2DR25D9133Indefinite Delivery Contract
- SPE2DR25D9133-SPE2DR26FCFM2Delivery Order
The Defense Logistics Agency awarded a $19,717.67 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the delivery of a Photrexa Cross-Linking Kit (6ml). The delivery order was issued on December 12, 2025, with an ultimate completion date of January 6, 2026, and carries no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. This award was issued under DMS Pharmaceutical Group's recently established Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy designed to ensure consistent pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has positioned itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its small business status to compete effectively while maintaining consistent performance across multiple product categories. The vendor's PPV-G GEN V contract, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. This contract authorizes the issuance of firm fixed-price delivery orders for branded and generic prescription medications, biologics, vaccines, and medical consumables to support recurring medical supply needs across the military healthcare system globally, positioning DMS Pharmaceutical Group as one of multiple regional prime vendor contractors supporting Department of Defense operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.7k | 12/11/25 |